13.02.2013 Views

Air Quality Criteria for Lead Volume II of II - (NEPIS)(EPA) - US ...

Air Quality Criteria for Lead Volume II of II - (NEPIS)(EPA) - US ...

Air Quality Criteria for Lead Volume II of II - (NEPIS)(EPA) - US ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

AX5-101<br />

Compound<br />

Table AX5-6.15. Genotoxic/Carcinogenic Effects <strong>of</strong> <strong>Lead</strong>—Epigenetic Effects and Mixture Interactions—Human<br />

Assay (Concentration and<br />

Exposure Time)<br />

Pb acetate Tyrosine aminotransferase<br />

expression and activity<br />

(0.3–10 µM <strong>for</strong> 24–48 h)<br />

PKC activity: 10 µM <strong>for</strong> 48 h<br />

Pb nitrate EROD/MROD activity<br />

(10–100 µM <strong>for</strong> 24 h)<br />

NAD(P)H: quinone<br />

oxidoreductase activity<br />

(10–100 µM <strong>for</strong> 24 h)<br />

Glutathione-S-transferase<br />

Ya activity (10–100 µM <strong>for</strong> 24 h)<br />

Pb nitrate NAD(P)H: quinone<br />

oxidoreductase activity<br />

(25 µM <strong>for</strong> 24 h)<br />

Glutathione-S-transferase Ya<br />

activity (25 µM <strong>for</strong> 24 h)<br />

Abbreviations<br />

Medium and Components<br />

DMEM—Dulbecco’s Minimal Essential Medium;<br />

FBS—Fetal Bovine Serum<br />

FCS—Fetal Calf Serum<br />

Cell Type<br />

and Culture<br />

Medium Co-exposure Effects Reference<br />

H4-<strong>II</strong>E-C3—<br />

human<br />

hepatoma cells<br />

in DMEM +<br />

2.5% FCS<br />

Hepa 1c1c7<br />

wild type cells<br />

in DMEM +<br />

10% FBS<br />

C12- AHRdeficient<br />

Hepa<br />

1c1c7 cells in<br />

DMEM + 10%<br />

FBS<br />

Dexamethasone<br />

(0.1 µM <strong>for</strong> 16 h),<br />

or calcium chloride<br />

(10 µM) or genistein<br />

(100 µM to block PKC<br />

activity)<br />

TCDD (0.1 nM),<br />

3-methyl cholanthrene<br />

(0.25 µM), betanaptflavone<br />

(10 µM),<br />

benzo(a)pyrene (1 µM)<br />

TCDD (0.1 nM),<br />

3-methyl cholanthrene<br />

(0.25 µM), betanaptflavone<br />

(10 µM),<br />

benzo(a)pyrene (1 µM)<br />

Differences between the serum types are unclear as insufficient details are provided by authors to distinguish.<br />

Pb acetate inhibited glucocorticoid –induction <strong>of</strong> tyrosine<br />

aminotransferase in a time- and dose-dependent manner.<br />

Co-treatment with calcium reduced the effects <strong>of</strong> Pb.<br />

Co-treatment with genistein increased the effects <strong>of</strong> Pb.<br />

Pb acetate decreases PKC activity and its translocation from the<br />

cytosol to the particulate cellular fraction.<br />

Pb did not affect EROD/MROD activity.<br />

Pb reduced CYP1A1 induction by TCDD, 3-methyl cholanthrene,<br />

beta-naptflavone, benzo(a)pyrene.<br />

Pb increased NAD(P)H: quinone oxidoreductase activity<br />

Pb increased NAD(P)H: quinone oxidoreductase activity induction by<br />

TCDD, 3-methyl cholanthrene, beta-naptflavone, benzo(a)pyrene.<br />

10 µM increased Glutathione-S-transferase Ya activity.<br />

25 and 100 µM increased Glutathione-S-transferase Ya activity.<br />

Pb nitrate did not affect Glutathione-S-transferase Ya induction by<br />

TCDD, 3-methyl cholanthrene, beta-naptflavone, benzo(a)pyrene.<br />

Pb nitrate did not increase NAD(P)H: quinone oxidoreductase and<br />

Glutathione-S-transferase Ya activity<br />

Pb increased NAD(P)H: quinone oxidoreductase activity induction by<br />

TCDD, 3-methyl cholanthrene, beta-naptflavone, benzo(a)pyrene.<br />

Pb did not affect Glutathione-S-transferase Ya induction by TCDD, 3methyl<br />

cholanthrene, beta-naptflavone, benzo(a)pyrene.<br />

Tonner and Heiman<br />

(1997)<br />

Korashy and<br />

El-Kadi (2004)<br />

Korashy and<br />

El Kadi (2004)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!